Cystospaz en es it fr

Cystospaz Brand names, Cystospaz Analogs

Cystospaz Brand Names Mixture

  • No information avaliable

Cystospaz Chemical_Formula


Cystospaz RX_link

Cystospaz fda sheet

Cystospaz msds (material safety sheet)

Cystospaz Synthesis Reference

Fodor et al., Acta Chem. Acad. Sci. Hung.28(4), 409 (1961)

Cystospaz Molecular Weight

289.369 g/mol

Cystospaz Melting Point


Cystospaz H2O Solubility

3.56 mg/mL

Cystospaz State


Cystospaz LogP


Cystospaz Dosage Forms

Tablets; Oral drops; Elixir; Injection

Cystospaz Indication

For treatment of bladder spasms, peptic ulcer disease, diverticulitis, colic, irritable bowel syndrome, cystitis, and pancreatitis. Also used to treat certain heart conditions, to control the symptoms of Parkinson's disease and rhinitis.

Cystospaz Pharmacology

L-Hyoscyamine, the active optical isomer of atropine (dl-hyoscyamine), is a tertiary amine anticholinergic gastrointestinal agent.

Cystospaz Absorption

Absorbed totally and completely by sublingual administration as well as oral administration.

Cystospaz side effects and Toxicity

Symptoms of overdose include headache, nausea, vomiting, blurred vision, dilated pupils, hot dry skin, dizziness, dryness of the mouth, difficulty in swallowing, and CNS stimulation. LD50=mg/kg(orally in rat)

Cystospaz Patient Information

Cystospaz Organisms Affected

Humans and other mammals